NCT07427901 Quality Of Life In Colorectal Cancer Survivors
| NCT ID | NCT07427901 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institute of Oncology Ljubljana |
| Condition | Colorectal Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 368 participants |
| Start Date | 2023-05-01 |
| Primary Completion | 2024-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 368 participants in total. It began in 2023-05-01 with a primary completion date of 2024-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to identify late adverse effects in colorectal cancer patients that may influence quality of life at 6, 12, and 24 months after oncological treatment. The study aims to assess quality of life in colorectal cancer survivors in relation to psycho-physical-social well-being at different time points and to evaluate the prevalence of late adverse effects and their association with diagnosis and specific oncological treatment.
Eligibility Criteria
Inclusion Criteria: * Patients with colorectal cancer (colon or rectal cancer) * Age 25 to 65 years * First oncological treatment performed at the Institute of Oncology Ljubljana * Working-capable patients * Ability to complete questionnaires * Ability to provide written informed consent Exclusion Criteria: * Age \< 25 years or \> 65 years * Patients unable to complete questionnaires * Patients unable to participate in follow-up assessments * Patients who do not provide written informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07427901 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07427901 currently recruiting?
Yes, NCT07427901 is actively recruiting participants. Contact the research team at kkorosec@onko-i.si for enrollment information.
Where is the NCT07427901 trial being conducted?
This trial is being conducted at Ljubljana, Slovenia.
Who is sponsoring the NCT07427901 clinical trial?
NCT07427901 is sponsored by Institute of Oncology Ljubljana. The trial plans to enroll 368 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.